CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)
暂无分享,去创建一个
R. Abagyan | Wenxu Zhou | J. McKerrow | A. Aksenov | C. M. Calvet | A. Debnath | M. Luth | L. Podust | Gareth Jennings | M. R. Luth | W. Nes | Gareth K. Jennings